. . . . . . . "[In this follow-on phase 1 trial, one dose of AAV2-hRPE65v2 (1.5?�?10(11) vector genomes) in a total volume of 300 ?L was subretinally injected into the contralateral, previously uninjected, eyes of 11 children and adults (aged 11-46 years at second administration) with inherited retinal dystrophy caused by RPE65 mutations, 1.71-4.58 years after the initial subretinal injection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:16:00+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .